Sensus Healthcare, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Sensus Healthcare, Inc. (SRTS) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $66.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-08-13
- Sensus Healthcare, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-06-30 was $66.00K, a 1.49% decline year-over-year.
- Sensus Healthcare, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-03-31 was $92.00K, a 42.86% decline year-over-year.
- Sensus Healthcare, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-09-30 was $67.00K, a 67.50% increase year-over-year.
- Sensus Healthcare, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-06-30 was $67.00K, a 67.50% increase year-over-year.
- Sensus Healthcare, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $359.00K, a 91.98% increase from fiscal 2022.
- Sensus Healthcare, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $187.00K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2024-06-30 | $66.00K 10-Q · filed 2024-08-13 | $158.00K derived: sum of 2 quarters · filed 2024-08-13 | ||
| 2024-03-31 | $92.00K 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | $359.00K 10-K · filed 2024-03-15 | |||
| 2023-09-30 | $67.00K 10-Q · filed 2023-11-13 | $134.00K derived: sum of 2 quarters · filed 2024-08-13 | $295.00K derived: sum of 3 quarters · filed 2024-08-13 | |
| 2023-06-30 | $67.00K 10-Q · filed 2024-08-13 | $228.00K derived: sum of 2 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $161.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $187.00K 10-K · filed 2024-03-15 | |||
| 2022-09-30 | $40.00K 10-Q · filed 2023-11-13 | $80.00K derived: sum of 2 quarters · filed 2023-11-13 | $137.00K derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | $40.00K 10-Q · filed 2023-11-13 | $97.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | $57.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |